[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369576-105":59,"doc-detail-369576-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","alterations-in-the-expression-of-a-set-of-mirnas-in-endometrial-cancer-and-their-correlation-with-clinical-variables-and-the-p53-signaling-pathway","Alterations in the Expression of a Set of miRNAs in Endometrial Cancer and Their Correlation with Clinical Variables and the p53 Signaling Pathway","","Endometrial cancer is among the most prevalent malignancies worldwide, with rising incidence and significant mortality. Current detection remains heterogeneous, often costly, invasive, and limited in specificity, motivating omics approaches. Using GSE268888 as a discovery cohort and TCGA as validation, the study identifies miRNAs overexpressed in endometrial cancer and links them to diagnostic and prognostic clinical variables, p53 signaling, and shared target TP53INP1, highlighting candidate biomarker value pending experimental confirmation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/alterations-in-the-expression-of-a-set-of-mirnas-in-endometrial-cancer-and-their-correlation-with-clinical-variables-and-the-p53-signaling-pathway/369576/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/alterations-in-the-expression-of-a-set-of-mirnas-in-endometrial-cancer-and-their-correlation-with-clinical-variables-and-the-p53-signaling-pathway/369576.png","ImageObject",300,407,{"name":92,"@type":93},"Fahsai","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What datasets were used to discover and validate the miRNA findings?","Question",{"text":112,"@type":113},"The discovery cohort used GSE268888, and the validation cohort used data from the TCGA consortium.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which miRNAs showed diagnostic and prognostic relevance in the study?",{"text":117,"@type":113},"hsa-miR-182 and hsa-miR-760 were reported as having diagnostic and prognostic relevance.",{"name":119,"@type":110,"acceptedAnswer":120},"How are the identified miRNAs connected to the p53 signaling pathway and TP53INP1?",{"text":121,"@type":113},"The miRNAs interacted with the p53 signaling pathway and shared TP53INP1 as a common target, with a positive correlation between the miRNAs and TP53INP1 in more advanced disease stages.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369576,1791248221,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549768702563,"https://ap-avatar.wpscdn.com/avatar/8000c4aa63b76e948b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786536092046926083","Article  \nAlterations in the Expression of a Set of miRNAs in Endometrial Cancer and Their Correlation with Clinical Variables and the p53 Signaling Pathway  \nJessica Alejandra Zapata García   \nAcademic Editor: Georgios Valsamakis  \nReceived: 17 March 2025  \nRevised: 26 April 2025  \nAccepted: 29 April 2025  \nPublished: 29 May 2025  \nCitation: Zapata García, J.A. Alterations in the Expression of a Set of miRNAsin Endometrial Cancer and Their Correlation with Clinical Variables and thep53 Signaling Pathway. Int. J. Mol. Sci. 2025, 26, 5215 . [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms26115215  \nCopyright: © 2025 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \nHealth Sciences Decan, Universidad Autonoma de Guadalajara, Zapopan 45129, Mexico; [genetica860@gmail.com](genetica860@gmail.com); Tel.: +52-332-287-26-73  \nAbstract: Endometrial cancer is the fifth most common cancer worldwide, with one of the highest incidence and mortality rates. Its incidence is projected to increase 55% by 2030 . Currently, the techniques used for its detection are heterogeneous and can be invasive and nonspecific. In this context, omics studies have gained relevance, providing solutions that have improved patient diagnosis and prognosis. In this study, we used data from the GSE268888 study as discovery cohort and data from the TCGA consortium as a validation cohort. Expression analyses were performed to identify miRNAs overexpressed in endometrial cancer. These miRNAs were then analyzed in relation to diagnostic and prognostic clinical variables. The target genes of these miRNAs were identified using bioinformatic tools, and functional enrichment analyses were conducted with this gene set to explore their involvement in relevant oncogenic signaling pathways. We also calculated the structural topology of the miRNA–target complexes and computed their correlation coefficients. We found that hsa-miR-182 and hsa-miR-760 had diagnostic and prognostic relevance and interacted with the p53 signaling pathway. Specifically, hsa-miR-449a was associated with diagnosis, but not with prognosis. Furthermore, we found that these miRNAs share TP53INP1 as a common target gene and estimated a high probability of complex formation, along with a positive correlation between these miRNAs and TP53INP1 in more advanced stages of the disease. These findings suggest that this miRNA signature has potential to be used as a diagnostic and prognostic biomarker and could serve as a foundation for future therapeutic strategies for endometrial cancer. However, further experimental validation is needed to confirm its clinical applicability.  \nKeywords: endometrial cancer; hsa-miR-182; hsa-miR-449a; hsa-miR-760; overall survival; relative risk; diagnosis; p53  \n1. Introduction  \nAccording to global statistics, endometrial cancer (EC) ranks as the fifth most common malignancy among the top fifteen cancer types, exhibiting some of the highest incidence and mortality rates worldwide, with rates of 14.1 and 7.1, per 100,000 individuals, respectively [1] . It is incidence is projected to increase 55% by 2030 [2] .  \nCurrently, there is no consensus regarding its detection. Common diagnostic techniques include transvaginal ultrasound, hysteroscopy, or endometrial biopsy, which can be expensive, invasive, or have low specificity [3] . Furthermore, when EC is diagnosed at advanced stages (II, III, and IV), patient prognosis tends to be poor [4] .  \nIn response to these challenges, microRNAs (miRNAs or miRs) have gained relevance. These small molecules are derived from DNA, and can interact with coding and non-coding  \nregions, or with the promoter regions of their target messenger RNAs","cbCaiprenXXtHdGA","https://ap.wps.com/l/cbCaiprenXXtHdGA","pdf",3777030,15,"English","# Abstract\n# 1. Introduction\n# 2. Results","[{\"question\":\"What datasets were used to discover and validate the miRNA findings?\",\"answer\":\"The discovery cohort used GSE268888, and the validation cohort used data from the TCGA consortium.\"},{\"question\":\"Which miRNAs showed diagnostic and prognostic relevance in the study?\",\"answer\":\"hsa-miR-182 and hsa-miR-760 were reported as having diagnostic and prognostic relevance.\"},{\"question\":\"How are the identified miRNAs connected to the p53 signaling pathway and TP53INP1?\",\"answer\":\"The miRNAs interacted with the p53 signaling pathway and shared TP53INP1 as a common target, with a positive correlation between the miRNAs and TP53INP1 in more advanced disease stages.\"}]","Alterations in the Expression of a Set of miRNAs in Endometrial Cancer and Their Correlation with Clinical Variables and the p53 Signaling Pathway | PDF",1790183506,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/74b2d3cd40c79147ae7c2f475d5736d9.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed1d059e8d82baa84e740a78a2b57542.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7b8186b413f14ac507130394d969430b.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/586a528a7927dcc1602402c32c637314.webp",980,1385]